BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 9740077)

  • 1. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
    Quinn MJ; Crotty KA; Thompson JF; Coates AS; O'Brien CJ; McCarthy WH
    Cancer; 1998 Sep; 83(6):1128-35. PubMed ID: 9740077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma.
    Posther KE; Selim MA; Mosca PJ; Stanley WE; Johnson JL; Tyler DS; Seigler HF
    Ann Surg Oncol; 2006 May; 13(5):728-39. PubMed ID: 16538415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases.
    Chen JY; Hruby G; Scolyer RA; Murali R; Hong A; Fitzgerald P; Pham TT; Quinn MJ; Thompson JF
    Cancer; 2008 Nov; 113(10):2770-8. PubMed ID: 18823042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of desmoplastic melanoma: a case-control comparison with other melanomas.
    Livestro DP; Muzikansky A; Kaine EM; Flotte TJ; Sober AJ; Mihm MC; Michaelson JS; Cosimi AB; Tanabe KK
    J Clin Oncol; 2005 Sep; 23(27):6739-46. PubMed ID: 16170181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients.
    Murali R; Shaw HM; Lai K; McCarthy SW; Quinn MJ; Stretch JR; Thompson JF; Scolyer RA
    Cancer; 2010 Sep; 116(17):4130-8. PubMed ID: 20564101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide excision without radiation for desmoplastic melanoma.
    Arora A; Lowe L; Su L; Rees R; Bradford C; Cimmino VC; Chang AE; Johnson TM; Sabel MS
    Cancer; 2005 Oct; 104(7):1462-7. PubMed ID: 16080180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoplastic melanoma: the role of radiotherapy in improving local control.
    Foote MC; Burmeister B; Burmeister E; Bayley G; Smithers BM
    ANZ J Surg; 2008 Apr; 78(4):273-6. PubMed ID: 18366400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.
    Sassen S; Shaw HM; Colman MH; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2008 Feb; 15(2):630-7. PubMed ID: 18080717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Lasithiotakis K; Leiter U; Meier F; Eigentler T; Metzler G; Moehrle M; Breuninger H; Garbe C
    Cancer; 2008 Apr; 112(8):1795-804. PubMed ID: 18306371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of recurrence in patients with melanoma after radical lymph node dissection.
    Nathansohn N; Schachter J; Gutman H
    Arch Surg; 2005 Dec; 140(12):1172-7. PubMed ID: 16365238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmoplastic and neurotropic melanoma.
    Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
    Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
    Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
    Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
    Shields CL
    Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
    Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma.
    Hawkins WG; Busam KJ; Ben-Porat L; Panageas KS; Coit DG; Gyorki DE; Linehan DC; Brady MS
    Ann Surg Oncol; 2005 Mar; 12(3):207-13. PubMed ID: 15827812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.